Meihao Medical Group Co., Ltd (HKG:1947)
0.5500
-0.0300 (-5.17%)
At close: Jun 5, 2026
Meihao Medical Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -14.34 | -32.42 | -13.59 | 28.46 | 32.07 |
Depreciation & Amortization | 14.62 | 14.01 | 14.03 | 13.1 | 10.88 |
Other Amortization | 0.19 | 0.16 | 0.16 | 0.21 | 0.1 |
Loss (Gain) From Sale of Assets | 0.42 | - | 0.17 | 0.06 | 0.07 |
Loss (Gain) From Sale of Investments | -0.7 | - | - | - | - |
Stock-Based Compensation | 1.29 | 9.81 | - | - | - |
Provision & Write-off of Bad Debts | -0 | 0 | 0.01 | -0.03 | -0.31 |
Other Operating Activities | 1.09 | -9.07 | -1.62 | -1.01 | 3.03 |
Change in Accounts Receivable | -0.12 | 0.17 | -0.27 | 0.1 | 0.42 |
Change in Inventory | -0.54 | 0.44 | -0.01 | -0.13 | -0.78 |
Change in Accounts Payable | 5.33 | -0.37 | 1.17 | -0.24 | 1.43 |
Change in Unearned Revenue | -0.19 | 0.38 | -0.92 | 0.03 | 1.02 |
Change in Other Net Operating Assets | 8.35 | -0.95 | 6.53 | -8.73 | -1.37 |
Operating Cash Flow | 15.39 | -17.85 | 5.63 | 31.81 | 46.56 |
Operating Cash Flow Growth | - | - | -82.29% | -31.67% | 69.59% |
Capital Expenditures | -9.32 | -1.9 | -5.58 | -7.65 | -17.96 |
Sale of Property, Plant & Equipment | 0.07 | - | - | 0.02 | - |
Cash Acquisitions | - | -6.09 | - | - | - |
Sale (Purchase) of Intangibles | -0.01 | -0.27 | - | -0.1 | -0.45 |
Investment in Securities | -3.38 | 45.14 | -69.65 | - | - |
Other Investing Activities | 2.95 | 3.7 | - | -0.89 | - |
Investing Cash Flow | -9.7 | 40.59 | -75.23 | -8.61 | -18.41 |
Long-Term Debt Issued | 13.55 | - | - | - | - |
Total Debt Issued | 13.55 | - | - | - | - |
Long-Term Debt Repaid | -5.38 | -6.34 | -5.92 | -7.11 | -34.52 |
Total Debt Repaid | -5.38 | -6.34 | -5.92 | -7.11 | -34.52 |
Net Debt Issued (Repaid) | 8.17 | -6.34 | -5.92 | -7.11 | -34.52 |
Issuance of Common Stock | - | - | 76.42 | 33.8 | - |
Repurchase of Common Stock | - | -19.25 | - | - | - |
Common Dividends Paid | - | -5.45 | - | - | - |
Other Financing Activities | -0.42 | -1.62 | -7.5 | -2.31 | -3.33 |
Financing Cash Flow | 7.75 | -32.66 | 63 | 24.37 | -37.84 |
Foreign Exchange Rate Adjustments | -1.69 | 1.59 | 3.9 | 0.67 | - |
Net Cash Flow | 11.75 | -8.33 | -2.7 | 48.25 | -9.69 |
Free Cash Flow | 6.07 | -19.75 | 0.05 | 24.17 | 28.6 |
Free Cash Flow Growth | - | - | -99.79% | -15.51% | 18.86% |
Free Cash Flow Margin | 5.97% | -26.45% | 0.07% | 18.97% | 27.16% |
Free Cash Flow Per Share | 0.01 | -0.03 | - | 0.05 | 0.06 |
Cash Interest Paid | 0.42 | 1.62 | 1.63 | 1.89 | 3.33 |
Cash Income Tax Paid | -8.22 | 9.16 | 9.31 | 13.33 | 10.78 |
Levered Free Cash Flow | 14.57 | -6.45 | 72.2 | -45.89 | 22.44 |
Unlevered Free Cash Flow | 14.91 | -5.44 | 73.22 | -44.71 | 23.98 |
Change in Working Capital | 12.83 | -0.33 | 6.5 | -8.97 | 0.73 |